By Dana Malcolm
Staff Writer
#USA, January 25, 2023 – In a matter of days, the United States is going to make a decision on whether or not they will make Covid-19 vaccinations an annual recommendation.
In an effort to reduce vaccine mistakes and increase compliance from the public the best way to administer COVID shots going forward is via a single vaccine shot for primary and booster doses according to a proposal from the US Food and Drug Administration (FDA).
The FDA said despite the fact that the fact that bivalent vaccines were proven to work, getting shots into arms was proving difficult with the agency citing “implementation complexities”.
In addition healthcare workers have made mistakes administering the vaccine owing to the number of different vial presentations and booster uptake is low all these issues are expected to be fixed or improved with the simplification of the vaccine composition.
The vaccine will have to be periodically updated to handle new variants but if the FDA gets its way gone will be the
era of multiple boosters. In fact the COVID shot will be more like the flu shot in how it is administered. Regulators will also vote on whether all shots should target the same variants. Of this is approved regulators would decide the most concerning variant in summer giving vaccine makers a chance to change the formulation in time for winter.
“Review of the totality of the available evidence on prior exposure to and vaccination against SARS-CoV-2 suggests that, moving forward, most individuals may only need to receive one dose of an approved or authorized COVID-19 vaccine to restore protective immunity for a period of time. Two doses of an approved or authorized COVID-19 vaccine may be needed to induce the expected protective immunity”
The Agency explained that though it was not completely the same the data observed in long term effectiveness of COVID shots was similar to that observed with annual influenza vaccination cementing their proposal.
The proposal will be considered this Thursday at the Vaccines and Related Biological Products Advisory Committee.
Even as yearly shots are considered, the US is holding fast to its vaccine mandate for entry.
This is despite most other countries relaxing the rules months prior. The vax rule came into effect during the initial onset of Omicron in November 2021. Prior to that only a negative test was needed. The measure was set to expire on January 9th but was quickly extended to April 10 this year.
The WHO has advised that travel bans and restrictions “do not provide added value and continue to contribute to the economic and social stress and safety measures such as masking, testing, isolation/quarantine, and vaccination should be based on risk assessments.
The country lengthened their vax mandate and activated more stringent entry measures, particularly for travellers from the China region, as new and elusive COVID sub-variants are emerging and infection rates are increasing.